Oregon Public Employees Retirement Fund’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,400
Closed -$941K 1512
2026
Q1
$941K Buy
+23,400
New +$504K 0.01% 875

Other funds holding APLS

Oregon Public Employees Retirement Fund's APLS Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 23,400 shares — an estimated $941K sold.

Oregon Public Employees Retirement Fund first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $941K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Oregon Public Employees Retirement Fund reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 23,400 Apellis Pharmaceuticals shares in Q2 2026, an estimated $941K.
  • Oregon Public Employees Retirement Fund first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Oregon Public Employees Retirement Fund's Apellis Pharmaceuticals position peaked at $941K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.